Quick Answer
Actinium Pharmaceuticals, Inc. reported Stockholders Equity of $7.83 million for fiscal year 2025.
Actinium Pharmaceuticals, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $7.83M | -76.1% |
| 2024 | $32.76M | -10.0% |
| 2023 | $36.38M | -45.3% |
| 2022 | $66.48M | -9.6% |
| 2021 | $73.55M | +19.9% |
| 2020 | $61.32M | +986.4% |
| 2019 | $5.64M | -36.0% |
| 2018 | $8.81M | -35.5% |
| 2017 | $13.67M | -24.1% |
| 2016 | $18.01M | -18.0% |
| 2015 | $21.97M | +1243.0% |
| 2014 | -$1.92M | -23.3% |
| 2013 | -$1.56M | -236.1% |
| 2012 | $1.15M | +15.5% |
| 2011 | $992.0K | +148.6% |
| 2010 | $399.1K | -52.8% |
| 2009 | $845.2K | -79.7% |
| 2008 | $4.16M | +20.2% |
| 2007 | $3.46M | +89.7% |
| 2006 | $1.82M | +2355.4% |
| 2005 | $74.3K | -83.1% |
| 2004 | $439.1K | -72.1% |
| 2003 | $1.57M | +193.9% |
| 2002 | -$1.68M | +3.3% |
| 2001 | -$1.73M | -256.4% |
| 2000 | $1.11M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $13.78M | -63.9% | -27.5% |
| June 30, 2025 | $19.01M | -56.6% | -26.0% |
| March 31, 2025 | $25.69M | -41.4% | -21.6% |
| December 31, 2024 | $32.76M | -10.0% | -14.3% |
| September 30, 2024 | $38.21M | -12.3% | -12.8% |
| June 30, 2024 | $43.84M | -17.4% | -0.1% |
| March 31, 2024 | $43.86M | -23.3% | +20.6% |
| December 31, 2023 | $36.38M | -45.3% | -16.5% |
- Actinium Pharmaceuticals, Inc. showed a decrease of -76.1% in Stockholders Equity compared to the prior fiscal year.
- Over the 2000–2025 period, Actinium Pharmaceuticals, Inc.’s stockholders equity has grown by 607.2% (from $1.11 million to $7.83 million).
- The most recent figure is from Actinium Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: